BIOMARKERS AND METHOD FOR PREDICTION OR PROGNOSIS OF THE RESPONSE TO TREATMENT WITH BRAF INHIBITORS AND MEK INHIBITORS (BRAFI + MEKI)

Disclosed are: biomarkers and a method for the prediction or prognosis of the response to treatment with BRAF inhibitors and MEK inhibitors (BRAFi + MEKi) in patients with mutated BRAF metastatic melanoma; a kit or device; and the uses thereof. Biomarcadores y método para predecir o pronosticar la r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CASTELLÓN RUBIO, Victoria Eugenia, BERCIANO GUERRERO, Miguel Ángel, NAVAS DELGADO, Ismael, TOSCANO MURILLO, Fátima, ONIEVA ZAFRA, Juan Luis, HENAO CARRASCO, Fernando, MOYA GARCÍA, Aurelio Ángel, LAVADO VALENZUELA, María del Rocío, SANCHO MÁRQUEZ, María Pilar, RUEDA DOMÍNGUEZ, Antonio, ALBA CONEJO, Emilio, VALDIVIA BAUTISTA, Javier, DE LA CRUZ MERINO, Luis, MONTESA PINO, Álvaro
Format:	Patent
Sprache:	eng ; fre ; spa
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed are: biomarkers and a method for the prediction or prognosis of the response to treatment with BRAF inhibitors and MEK inhibitors (BRAFi + MEKi) in patients with mutated BRAF metastatic melanoma; a kit or device; and the uses thereof. Biomarcadores y método para predecir o pronosticar la respuesta al tratamiento con inhibidores de BRAF y de MEK (BRAFi + MEKi) de los pacientes que padecen melanoma metastásico BRAF mutado, kit o dispositivo y usos. L'invention concerne des biomarqueurs et un procédé de prédiction ou de pronostic de la réponse au traitement avec des inhibiteurs de BRAF et de MEK (BRAFi + MEKi) de patients souffrant de mélanome métastasique BRAF muté, un kit ou un dispositif et leurs utilisations.